Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, especially for cancers where cure selections remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline We're https://financefeeds.com/ryu-hirayama-joins-lseg-as-country-representative-for-japan/